Maze Therapeutics Inc MAZE Edges Higher Tests Key Resistance Zone Market Declines Amid Profit Booking Analyst Highlights Three Stocks for Potential Consideration DTW Q1 2026 Earnings EPS Misses Estimates by 387 on LowerthanExpected Performance Nomura Warns RBIs Latest Rate Cut May Dilute Policy Framework